VORETIGENE NEPARVOVEC-RZYL

VORETIGENE NEPARVOVEC-RZYL was reported 152 times

VORETIGENE NEPARVOVEC-RZYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYMPATHETIC OPHTHALMIA 1 0.0625
1 RETINAL FOVEA DISORDER 1 0.0400
2 CHORIORETINAL ATROPHY 8 0.0386
3 RETINAL DEPIGMENTATION 8 0.0261
4 VITREOUS ADHESIONS 2 0.0174
5 LOSS OF VISUAL CONTRAST SENSITIVITY 1 0.0159
6 CHORIORETINAL FOLDS 1 0.0141
7 CENTRAL VISION LOSS 3 0.0135
8 ROSEOLA 1 0.0123
9 RETINAL DEGENERATION 15 0.0115
10 VITREAL CELLS 2 0.0099
11 RETINAL DEPOSITS 2 0.0099
12 RHEGMATOGENOUS RETINAL DETACHMENT 2 0.0096
13 INTRA-OCULAR INJECTION COMPLICATION 2 0.0088
14 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 1 0.0062
15 VITREOUS OPACITIES 5 0.0059
16 INTRAOCULAR PRESSURE DECREASED 3 0.0057
17 EYELID INJURY 1 0.0057
18 CHORIORETINAL DISORDER 1 0.0051
19 VISUAL BRIGHTNESS 2 0.0051
20 LENTICULAR OPACITIES 2 0.0046
21 VOGT-KOYANAGI-HARADA DISEASE 1 0.0045
22 SUTURE RELATED COMPLICATION 3 0.0042
23 POST PROCEDURAL FEVER 1 0.0041
24 CATARACT SUBCAPSULAR 2 0.0033
25 RETINAL TEAR 8 0.0032
26 POST PROCEDURAL INFLAMMATION 2 0.0032
27 OCULAR HYPERTENSION 6 0.0031
28 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
29 OPTIC ATROPHY 3 0.0018
30 INTRAOCULAR PRESSURE INCREASED 22 0.0017
31 EPISCLERITIS 1 0.0014
32 ANTERIOR CHAMBER CELL 1 0.0014
33 NIGHT BLINDNESS 2 0.0012
34 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
35 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
36 VITREOUS HAEMORRHAGE 2 0.0007
37 VASCULAR INJURY 1 0.0007
38 PHOTOPSIA 4 0.0006
39 EYE INFLAMMATION 6 0.0006
40 CONJUNCTIVAL HYPERAEMIA 2 0.0006
41 VITRITIS 1 0.0005
42 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
43 POST PROCEDURAL DISCOMFORT 1 0.0005
44 EYE OEDEMA 1 0.0004
45 STRABISMUS 1 0.0003
46 IRITIS 1 0.0003
47 SUSPECTED COVID-19 1 0.0003
48 VISUAL FIELD DEFECT 2 0.0003
49 TESTIS CANCER 1 0.0003
50 RETINAL DETACHMENT 2 0.0002
51 EYE PAIN 12 0.0002
52 FACE OEDEMA 3 0.0002
53 CATARACT OPERATION 1 0.0002
54 MENTAL IMPAIRMENT 4 0.0002
55 EYE HAEMORRHAGE 2 0.0001
56 OCULAR HYPERAEMIA 7 0.0001
57 EYE MOVEMENT DISORDER 1 0.0001
58 RETINAL HAEMORRHAGE 1 0.0001
59 CATARACT 8 0.0001
60 BLINDNESS 5 0.0001
61 PHOTOPHOBIA 2 0.0001
62 VITREOUS FLOATERS 1 0.0001
63 EYELID PTOSIS 1 0.0001
64 VISUAL IMPAIRMENT 12 0.0001
65 EYE DISCHARGE 1 0.0001
66 PHARYNGITIS STREPTOCOCCAL 1 0.0001
67 VISUAL ACUITY REDUCED 3 0.0001
68 OCULAR DISCOMFORT 1 0.0001
69 METASTASES TO LUNG 1 0.0001
70 DISCOMFORT 5 0.0001
71 PROCEDURAL PAIN 2 0.0001
72 EYE IRRITATION 4 0.0001
73 ANOSMIA 1 0.0001
74 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
75 MENINGIOMA 1 0.0001
76 EYE SWELLING 2 0.0001
77 GLAUCOMA 1 0.0001
78 VISION BLURRED 7 0.0001
79 DEPRESSED MOOD 2 0.0000
80 EAR INFECTION 1 0.0000
81 LACRIMATION INCREASED 1 0.0000
82 GAIT INABILITY 1 0.0000
83 EYE PRURITUS 1 0.0000
84 DEVICE DISLOCATION 1 0.0000
85 DISTURBANCE IN ATTENTION 1 0.0000
86 BLISTER 1 0.0000
87 SEIZURE 2 0.0000
88 DISEASE PROGRESSION 2 0.0000
89 ILL-DEFINED DISORDER 1 0.0000
90 VERTIGO 1 0.0000
91 BALANCE DISORDER 1 0.0000
92 OROPHARYNGEAL PAIN 1 0.0000
93 MIGRAINE 1 0.0000
94 ATRIAL FIBRILLATION 1 0.0000
95 PYREXIA 3 0.0000
96 CHILLS 1 0.0000
97 HYPERHIDROSIS 1 0.0000
98 ANXIETY 2 0.0000
99 HEADACHE 4 0.0000
100 MYOCARDIAL INFARCTION 1 0.0000
101 COVID-19 1 0.0000
102 NASOPHARYNGITIS 1 0.0000
103 PRODUCT USE ISSUE 1 0.0000
104 RASH 2 0.0000
105 DRUG INEFFECTIVE 6 0.0000
106 FEELING ABNORMAL 1 0.0000
107 DIZZINESS 2 0.0000
108 INSOMNIA 1 0.0000
109 COUGH 1 0.0000
110 CONDITION AGGRAVATED 1 0.0000
111 OFF LABEL USE 2 0.0000
112 VOMITING 1 0.0000
113 DEATH 1 0.0000